By BOPA Research Committee on 21st November 2024

National survey about the implementation of JDBS/UK chemo board guidelines on the management of glycaemia in people with cancer

National survey about the implementation of JDBS/UK chemo board guidelines on the management of glycaemia in people with cancer. The purpose is to understand some of the enablers and barriers…

Read article
By BOPA Committee on 18th November 2024

ISOPP CAPhO Symposium 2025

ISOPP CAPhO Symposium 2025 (ISOPP CAPhO 2025) is taking place April 3-6 (Symposium) and April 7 (Masterclasses) at the Victoria Conference Centre, Victoria, British Columbia, Canada. The Symposium is hosted…

Read article
By BOPA Education and Training Subcommittee on 18th November 2024

Project to link members to MPharm course in the UK

Dear BOPA Members, The Education & Training subcommittee are working on a project to link BOPA members into every undergraduate MPharm course in the UK, with the aim of providing…

Read article
By EDI Subcommittee on 8th November 2024

BOPA EDI membership survey

We invite you to take part in a quick BOPA EDI membership survey. Your responses will assist the BOPA Equity, Diversity and Inclusion (EDI) subcommittee to better serve the membership…

Read article
By BOPA Research Committee on 8th November 2024

Healthcare Professional’s Experiences & Perceptions of Switching Brands of oral SACT – Survey

Dear BOPA members In cancer care, little is known about the impact of specific brands of oral SACT medication or how healthcare professionals respond and process brand switches of oral…

Read article
By BOPA Passport pillar on 6th November 2024

Request for membership to create or review content for BOPA Digital SACT passport (Update)

Dear Member, Regarding the earlier communication for registering to become a creator/reviewer of mock prescriptions: This process has been amended and creation/review is open to free associates and above, as…

Read article
By Netty Cracknell on 6th November 2024

Independent Sector Cancer Network (ISCN) Publish NEW Cancer Service Guidelines

The Independent Sector Cancer Network (ISCN) is a strategic quality governance and safety group which aims to improve independard sector cancer provision though effective collaboration and sharing of best practice across the…

Read article
By Joseph Williams on 6th November 2024

Hospital practices concerning the in-use storage time of (reconstituted) oncology medicines

Dear BOPA Members, The EDQM (the European Directorate for the Quality of Medicines&Healthcare of the Council of Europe) is conducting a survey following a study from national monitoring activities, which…

Read article
By Joseph Williams on 5th November 2024

New Publication by BOPA Member and AI Specialist Advisory Group (SAG) Co-Chair Pinkie Chambers

From prediction to practice: mitigating bias and data shift in machine-learning models for chemotherapy-induced organ dysfunction across unseen cancers New Publication by BOPA Member and AI Specialist Advisory Group (SAG)…

Read article
By BOPA Executive Committee on 4th November 2024

CRUK Consent Form Updates – MPN and Nivolumab with Relatlimab for melanoma

Dear All, I am happy to inform you that the MPN consent forms have been reviewed and updated. Furthermore, a new consent form has been added  form for Nivolumab with…

Read article
By BOPA Committee on 4th November 2024

BOPA Podcast – Let’s Talk About Acute Oncology

The next episode of Let’s Talk About SACT is Let’s talk about Acute Oncology. In this episode we are joined by Caroline Wilson and Alison Taylor. We discuss what acute…

Read article
By BOPA Passport pillar on 28th October 2024

Request for membership to create or review content for BOPA Digital SACT passport

Dear Member, It has been 12 months since the launch of the “BOPA SACT Verification Passport”. In order to optimise user experience of the Passport, we need to have new…

Read article